FeesSafety
Pluang+

OraSure to report Q3 2026 earnings on Nov 9 with a live webcast call.

Company Fundamentals
26 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
OraSure to report Q3 2026 earnings on Nov 9 with a live webcast call.

OraSure Technologies will announce its third quarter 2026 financial results on November 9, 2026, after market close. The company will hold a conference call at 5:00 p.m. Eastern Time to discuss the results, accessible via webcast on its investor relations website. This update is important for investors tracking OraSure's performance in the diagnostic test and healthcare solutions market. The webcast will be archived for about a year for later access.

OraSure Technologies will announce its Q3 2026 results on November 9. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 27, 2026 03:11 WIB: Out of 150 health stocks, 80 rose and 70 fell. Summit Therapeutics Inc (SMMT) traded at USD 14.48 with a 1-day change of -6.37% and a typical hold time of 17 days. Smith & Nephew plc (SNN) was priced at USD 30.85, up 5.54%, with 100% sell order activity. Tango Therapeutics Inc. (TNGX) traded at USD 22.09, down 5.36%, with 86% buy order activity and a 2-day hold time.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
23 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
23 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
35 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App